Expanding into the commercial supply space

EuroBiotech_ Where does Celonic stand today, and where do you want to place your company in the long term?
Bracht_The acquisition of Glycotope’s manufacturing business we announced last winter is the starting point for a major expansion of our business focus. We have looked for awhile for a strategic acquisition to expand Celonic’s business focus from clinical trial supply to Phase III and commercial GMP manufacturing, which would allow long-term partnerships from early to commercial phases. In Basel, however, we were very confined, and a capacity expansion was a clear strategic focus for us. So, we thought about how to establish an integrated…